Novavax (NVAX) EPS (Basic) Growth (1y) (2011 - 2026)
Novavax (NVAX) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-51.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
186.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
104.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-52.19% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-100.01% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
-101.86% |
| Date | Value |
|---|
| Mar 31, 2026 |
-101.86% |
| Dec 31, 2025 |
121.15% |
| Sep 30, 2025 |
-64.47% |
| Jun 30, 2025 |
-39.45% |
| Mar 31, 2025 |
406.67% |
| Dec 31, 2024 |
64.63% |
| Sep 30, 2024 |
39.68% |
| Jun 30, 2024 |
67.69% |
| Mar 31, 2024 |
69.21% |
| Dec 31, 2023 |
35.81% |
| Sep 30, 2023 |
41.40% |
| Jun 30, 2023 |
109.95% |
| Mar 31, 2023 |
-228.20% |
| Dec 31, 2022 |
79.75% |
| Sep 30, 2022 |
50.12% |
| Jun 30, 2022 |
-37.47% |
| Mar 31, 2022 |
187.21% |
| Dec 31, 2021 |
-292.71% |
| Sep 30, 2021 |
-34.27% |
| Jun 30, 2021 |
-1,483.33% |
